长期血清尿酸变化与糖尿病视网膜病变之间的关联:一类和二类糖尿病患者的前性研究
Qian Zhu1, Hanying Wang1, Yuan Qu1
1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
高血清尿酸变异性与糖尿病视网膜病变 (DR) 的发展和糖尿病患者的恶化有关. 维持稳定的血清尿酸水平对于控制DR进展至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
- 代谢研究研究 代谢研究
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病中视力丧失的主要原因之一.
- 血清尿酸 (SUA) 水平已与DR病原发生有关,但SUA变异性的作用尚不清楚.
- 了解影响DR进展的因素对于有效的患者管理至关重要.
研究的目的:
- 调查血清尿酸 (SUA) 变化与糖尿病视网膜病变 (DR) 的发生率和进展之间的关联.
- 评估SUA波动对DR严重程度对1型和2型糖尿病患者的影响.
- 确定SUA变异性是否是DR发展和恶化的独立风险因素.
主要方法:
- 一项前性队列研究,涉及730名在基线没有增殖性DR的DM患者.
- 随访至少一年,定期进行DR评估 (基金照片) 和SUA测量.
- 计算平均真实可变性 (ARV) 来量化SUA波动,调整后续频率.
主要成果:
- 卡普兰-梅尔分析表明,在SUAARV升高的患者中,DR发展和进展的可能性更高 (Log-rank p=0.0055).
- 考克斯回归显示,与第一四分位相比,SUA ARV的第三 (HR 2.2,p=0.008) 和第四 (HR 2.74,p=0.017) 四分位数中DR恶化的危险比率显著增加.
- 这些发现凸显了SUA变异性作为DR进展的重要预测因素.
结论:
- 长期高血清尿酸变异与DM患者糖尿病视网膜病变的发展和恶化有显著的关联.
- 持续控制和稳定血清尿酸水平可能有助于预防或减缓DR进展.
- 监测SUA变异性可能为糖尿病患者的DR风险分层和管理提供一种新的方法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation


